Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis

JR Hurst; M Dilleen; K Morris; S Hills; B Emir; R Jones

doi:10.2147/copd.s153655

Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis

JR Hurst, M Dilleen, K Morris, S Hills, B Emir, R Jones

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

19 Downloads (Pure)

Original language	English
Pages (from-to)	781-792
Number of pages	0
Journal	International Journal of Chronic Obstructive Pulmonary Disease
Volume	0
Issue number	0
DOIs	https://doi.org/10.2147/copd.s153655
Publication status	E-pub ahead of print - Mar 2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2147/copd.s153655

Hurst et al

Cite this

Hurst, JR., Dilleen, M., Morris, K., Hills, S., Emir, B., & Jones, R. (2018). Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis. International Journal of Chronic Obstructive Pulmonary Disease, 0(0), 781-792. Advance online publication. https://doi.org/10.2147/copd.s153655

@article{e6fcd06372cd4d11b0193e3bd2b42094,

title = "Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis",

author = "JR Hurst and M Dilleen and K Morris and S Hills and B Emir and R Jones",

year = "2018",

month = mar,

doi = "10.2147/copd.s153655",

language = "English",

volume = "0",

pages = "781--792",

journal = "International Journal of Chronic Obstructive Pulmonary Disease",

issn = "1178-2005",

number = "0",

}

Hurst, JR, Dilleen, M, Morris, K, Hills, S, Emir, B & Jones, R 2018, 'Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis', International Journal of Chronic Obstructive Pulmonary Disease, vol. 0, no. 0, pp. 781-792. https://doi.org/10.2147/copd.s153655

Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis. / Hurst, JR; Dilleen, M; Morris, K et al.
In: International Journal of Chronic Obstructive Pulmonary Disease, Vol. 0, No. 0, 03.2018, p. 781-792.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis

AU - Hurst, JR

AU - Dilleen, M

AU - Morris, K

AU - Hills, S

AU - Emir, B

AU - Jones, R

PY - 2018/3

Y1 - 2018/3

UR - https://pearl.plymouth.ac.uk/pms-research/883/

U2 - 10.2147/copd.s153655

DO - 10.2147/copd.s153655

M3 - Article

SN - 1178-2005

VL - 0

SP - 781

EP - 792

JO - International Journal of Chronic Obstructive Pulmonary Disease

JF - International Journal of Chronic Obstructive Pulmonary Disease

IS - 0

ER -

Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis

UN SDGs

Access to Document

Other files and links

Cite this